Please download the dossier by clicking on the dossier button x
×

USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OR PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS

  • US 20080311112A1
  • Filed: 04/17/2008
  • Published: 12/18/2008
  • Est. Priority Date: 04/19/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating necrotizing enterocolitis in a subject in need of such treatment comprising administering, to the subject, an effective amount of a TLR9 agonist.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×